Literature DB >> 23873990

Liver fat has a stronger association with risk factors for type 2 diabetes in African-American compared with Hispanic adolescents.

Tanya L Alderete1, Claudia M Toledo-Corral, Preeya Desai, Marc J Weigensberg, Michael I Goran.   

Abstract

CONTEXT: Although overweight and obese African-Americans (AAs) have less visceral adipose tissue (VAT) and liver fat (LF) than Hispanics, they have a similar risk for type 2 diabetes.
OBJECTIVE: We examined ethnic differences in the association between VAT and LF with risk factors for type 2 diabetes to help explain this paradox.
DESIGN: We conducted a cross-sectional study in an academic pediatric care facility.
SUBJECTS: Subjects were overweight and obese AA (n = 131; 15.5 ± 3.3 years old) and Hispanic adolescents (n = 227; 14.7 ± 3.0 years old). MAIN OUTCOME MEASURES: Outcome measures included insulin sensitivity (SI), acute insulin response (AIR), and disposition index (DI) by frequently sampled i.v. glucose tolerance test and minimal modeling.
RESULTS: LF, not VAT, was inversely associated with SI, and the effect of high LF compared with low was more pronounced in AAs (P(interaction) < .05). In Hispanics, high LF was associated with a 24% lower SI (P < .01) and a 31% increase in AIR (P < .01) and was not associated with DI (P = .35). In AAs, high LF was associated with a 49% lower SI (P < .001), was not associated with an increase in AIR (P = .25), and was associated with a 42% lower DI (P < .01), indicating failure of compensatory insulin secretion/clearance in response to insulin resistance. Prediabetes changed the relationship between high/low LF and DI in Hispanics (P(interaction) = .002) but not AAs such that prediabetic Hispanics with high LF had a 43% lower DI (P = .03) with no difference in those without prediabetes (P = .06).
CONCLUSIONS: LF has a stronger effect on SI compared with VAT. Our results suggest that the impact of high LF on poor β-cell compensation is more pronounced in AAs. In Hispanics, the combination of high LF and prediabetes contributes to poor β-cell compensation.

Entities:  

Mesh:

Year:  2013        PMID: 23873990      PMCID: PMC3763973          DOI: 10.1210/jc.2013-1138

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

Review 1.  Relation between visceral fat and disease risk in children and adolescents.

Authors:  M I Goran; B A Gower
Journal:  Am J Clin Nutr       Date:  1999-07       Impact factor: 7.045

2.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

3.  Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction.

Authors:  G H Glover; E Schneider
Journal:  Magn Reson Med       Date:  1991-04       Impact factor: 4.668

Review 4.  Abdominal obesity and fatty liver.

Authors:  M U Jakobsen; T Berentzen; T I A Sørensen; K Overvad
Journal:  Epidemiol Rev       Date:  2007-05-02       Impact factor: 6.222

5.  Metabolic effects of visceral fat accumulation in type 2 diabetes.

Authors:  Amalia Gastaldelli; Yoshinori Miyazaki; Maura Pettiti; Masafumi Matsuda; Srihanth Mahankali; Eleonora Santini; Ralph A DeFronzo; Ele Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

Review 6.  Accurate assessment of beta-cell function: the hyperbolic correction.

Authors:  Richard N Bergman; Marilyn Ader; Katrin Huecking; Gregg Van Citters
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

7.  Insulin resistance and associated compensatory responses in african-american and Hispanic children.

Authors:  Michael I Goran; Richard N Bergman; Martha L Cruz; Richard Watanabe
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

8.  Ectopic fat deposition in prediabetic overweight and obese minority adolescents.

Authors:  Claudia M Toledo-Corral; Tanya L Alderete; Houchun H Hu; Krishna Nayak; Sherryl Esplana; Ting Liu; Michael I Goran; Marc J Weigensberg
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

9.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

Authors:  S Lillioja; D M Mott; M Spraul; R Ferraro; J E Foley; E Ravussin; W C Knowler; P H Bennett; C Bogardus
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes.

Authors:  Martha L Cruz; Richard N Bergman; Michael I Goran
Journal:  Diabetes Care       Date:  2002-09       Impact factor: 19.112

View more
  14 in total

1.  Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects.

Authors:  Nathan S Artz; William M Haufe; Catherine A Hooker; Gavin Hamilton; Tanya Wolfson; Guilherme M Campos; Anthony C Gamst; Jeffrey B Schwimmer; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2015-01-23       Impact factor: 4.813

Review 2.  Metabolic basis of ethnic differences in diabetes risk in overweight and obese youth.

Authors:  Tanya L Alderete; Claudia M Toledo-Corral; Michael I Goran
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

3.  Association of ectopic fat with abdominal aorto-illiac and coronary artery calcification in african ancestry men.

Authors:  Allison L Kuipers; Joseph M Zmuda; J Jeffrey Carr; James G Terry; Sangeeta Nair; Ryan Cvejkus; Clareann H Bunker; Alan L Patrick; Christina L Wassel; Iva Miljkovic
Journal:  Atherosclerosis       Date:  2017-06-16       Impact factor: 5.162

4.  Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women.

Authors:  Jennifer L Rehm; Peter M Wolfgram; Diego Hernando; Jens C Eickhoff; David B Allen; Scott B Reeder
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

5.  Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Michele Di Martino; Caterina Anania; Gian Marco Andreoli; Mario Bezzi; Carlo Catalano; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

6.  Hepatic and Skeletal Muscle Adiposity Are Associated with Diabetes Independent of Visceral Adiposity in Nonobese African-Caribbean Men.

Authors:  Iva Miljkovic; Allison L Kuipers; Ryan K Cvejkus; J Jeffrey Carr; James G Terry; Bharat Thyagarajan; Victor W Wheeler; Sangeeta Nair; Joseph M Zmuda
Journal:  Metab Syndr Relat Disord       Date:  2020-05-11       Impact factor: 1.894

Review 7.  Novel Risk Factors for Type 2 Diabetes in African-Americans.

Authors:  Ranee Chatterjee; Nisa M Maruthur; David Edelman
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

8.  Temporal relationships between adipocytokines and diabetes risk in Hispanic adolescents with obesity.

Authors:  Brandon D Kayser; Claudia M Toledo-Corral; Tanya L Alderete; Marc J Weigensberg; Michael I Goran
Journal:  Obesity (Silver Spring)       Date:  2015-06-05       Impact factor: 5.002

9.  A comparison of liver fat fraction measurement on MRI at 3T and 1.5T.

Authors:  Lavanya Athithan; Gaurav S Gulsin; Michael J House; Wenjie Pang; Emer M Brady; Joanne Wormleighton; Kelly S Parke; Matthew Graham-Brown; Tim G St Pierre; Eylem Levelt; Gerry P McCann
Journal:  PLoS One       Date:  2021-07-13       Impact factor: 3.240

10.  Hepatic Fat in Early Childhood Is Independently Associated With Estimated Insulin Resistance: The Healthy Start Study.

Authors:  Catherine C Cohen; Wei Perng; Shikha S Sundaram; Ann Scherzinger; Kartik Shankar; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.